Stable aqueous colloids of ZnS nanoparticles have been synthesised using zinc acetate, sodium sulfide and asymmetric double hydrophilic block copolymers PAA-b-PAM (polyacrylic acid-block-polyacrylamide) with various block molecular weights: MPAA = 1000, 3000, 5000 g mol−1 and MPAM = 10 000, 15 000, 30 000 g mol−1, respectively. The synthesis involves the formation of precursor hybrid polyion complex (HPIC) micelles, in which the micelle core is composed of Zn2+ ions complexed by polyacrylate blocks, while the corona is constituted by the stabilising neutral PAM blocks. The addition of S2− ions in the micelle solutions yields ZnS nanoparticles with a diameter of 3–4 nm. The ZnS nanoparticle size is weakly dependent on the copolymer block length, while the particle size distribution correlates with the copolymer asymmetry degree in such a way that a higher MPAM/MPAA ratio yields particles with a narrower size distribution. Characterisation by XRD and SEAD revealed that ZnS has a cubic sphalerite structure with the cell parameter a = 5.25 ± 0.05 Å that is smaller than that of the bulk material (a = 5.406 ± 0.05 Å). The obtained colloids present photoluminescent properties with an emission band peaking at 410 nm and exhibit a blue-shift of the band-gap energy in the UV-visible absorption spectra due to the quantum-confinement effect.
No takes yet. Share an insight, caveat, or question.
Тарасов et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: